Team

Sean Parrish, a founder and Managing Director of Hope Capital Advisors. Has extensive experience in valuation, due diligence, and value growth advisory. Sean has advised on $200 million of transactions. Sean’s financial expertise combined with his marketing skill set and an extensive network of Debt Financiers, Private Equity, Venture Capital, and Family Offices provides the perfect combination to close deals for clients. Sean also served six years in the United State Marine Corps and attended Northeastern University.

John Raymond is the Principal at Hope Capital Advisor. John brings over 40 years advising on $2.5 billion of transactions. John’s vast knowledge of finance and accounting help clients understand any complex financial situation as well guide clients throughout the transaction process. John runs the Due Diligence team at Hope Capital Advisors but also is pulled in to help guide clients on all things finance related throughout the process of any transactions.

Andrew Parrish Jr., a founder and partner of Hope Capital Advisors combines his financial expertise and sales experience to help clients meet their business goals. Andrew holds an MBA and runs our sales and marketing team. Andrew guides clients through the process from start to finish assisting them in reaching out to investors, building the assets needed to help clients raise funds, or find a buyer. Andrew also has an extensive network of Private Equity, Venture Capital, banks, and other investors he can bring your deal to. Prior to founding Hope Capital Advisors Andrew served six years in the Marines Corps.

James Parrish, a founder and Partner at Hope Capital Advisors. Brings to Hope Capital Advisors a background in economics. James couples his background in economics with his network of investors to help perform industry analysis during valuation and due diligence. James also has a marketing background and helps Andrew run the marketing division of Hope Capital Advisors. James holds a bachelor's degree in economics and also served six years in the United State Marine Corps.

Paul Stocker is the Senior Accountant at Hope Capital Advisors. Paul is a CPA and brings over 40 years of experience in corporate and tax accounting to our team. Paul provides advisory services to clients throughout the transaction process. Paul can help guide clients through the tax issues they can run into during business transactions.

Jerry is an accomplished capital advisor, with 35 years of experience Jerry has raised $1.75B in equity for small and large companies as well as funds. He was formerly the Director of Investor Relations for several NYSE & OTC listed public corporations, Senior Vice President, Regional Vice President and Financial Advisor for several prominent global financial firms, including Strategic Capital Distributors, Essex Corporation, Bank of America Investments, Transamerica, and Aegon Insurance Group.  He has extensive experience with alternative & traditional investment products, strategies and capital markets functions, specializing in raising capital. Jerry has successfully raised capital from Financial Advisors, RIAs, Family Offices, Institutions, Endowments and High Net Worth (Accredited) investors.

Ashwin brings 18 years of investment banking experience to the Hope Capital team. Ashwin has extensive experience in originating, evaluating, and managing M&A deals across a range of strategic processes. Ashwin has closed a wide range of transactions of complex M&A transactions across many different industries totaling over $4B in deals closed.

Former Head of Strategic Partnerships at Burgiss, Robert is an experienced investment executive with expertise in capital raising, M&A, and strategic growth. Skilled in building global partnerships, executing due diligence, and structuring complex deals, Robert has a proven track record of driving value through innovative solutions and operational excellence, delivering impactful outcomes across the investment lifecycle.

Drew, a seasoned banking executive with 33+ years of experience, co-founded Revere Bank, serving as Co-President and CEO. He has held leadership roles at Mercantile Potomac Bank and the U.S. Treasury. A graduate of Mount St. Mary’s, he brings strategic insight and financial expertise to Hope Capital Advisors.

Nick is a seasoned private equity professional with expertise in capital raising, strategic investments, and aviation finance. With an MBA in Finance from Columbia Southern University and a background in aviation technology, he transitioned from corporate aviation to private equity in 2017. As a registered Series 7 and Series 63 professional, he specializes in private equity fund placement, investor relations, and asset management. Having worked with numerous private equity and venture funds, Nick leverages his extensive institutional network to source and execute deals. Since 2017, he has raised capital across a wide range of industries—including biotech, real estate, aviation, technology, agriculture, private equity, media & entertainment, and venture capital—totaling $875 million in capital raised.

Dr. Zahid Moneer is a seasoned leader in healthcare investment banking, with over 15 years of experience (Nomura, HSBC, BNP Paribas) orchestrating transformative M&A and Capital Raise transactions totalling c.$250bn
in the Pharma, Biotech and Healthcare Services industries. His work is centered on driving strategic innovation and delivering impactful financial solutions for global healthcare clients.
Zahid's academic foundation includes a Ph.D. in Pharmacology, M.Phil in Biochemistry and an Executive MBA all from the University of Cambridge. He has consistently demonstrated exceptional leadership and deep sector insights, earning the trust of multinational healthcare companies and Private Equity.
Some of his standout deals include advising Roche on its $20.7 billion buy-back from Novartis, sale of Doc Generici to TPG, Spin of EuroAPI from Sanofi, multiple product divestments from Sanofi's GenMed business, Neuraxpharm/Permira on the acquisition of a CNS portfolio €2.3 billion Galderma IPO and Takeda’s $64 billion acquisition of Shire.